Tackling gliomas with nanoformulated antineoplastic drugs: suitability of hyaluronic acid nanoparticles.
Department of Biomedical Engineering, University of Cagliari, Cagliari, Italy, mario.ganau@singularityu.org.
M
M
Ganau
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D004337:Drug Carriers / Q000493:pharmacokinetics / Q000627:therapeutic use; D004355:Drug Stability; D005910:Glioma / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D006820:Hyaluronic Acid / Q000737:chemistry* / Q000493:pharmacokinetics; D053758:Nanoparticles / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D004337:Drug Carriers; D006820:Hyaluronic Acid